Saccharomyces boulardii and infection due to Giardia lamblia
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Therapy with metronidazole is the recommended option in giardiasis. However, some clinical trial reports suggest the appearance of drug resistance to explain therapeutic failure. Several investigations have been carried out on the effect of probiotic microorganisms for preventing or treating gastrointestinal diseases, but little is known about their efficacy against protozoal infections. The principal objective of our study was to evaluate the efficacy of Saccharomyces boulardii against Giardia lamblia infections. A double-blind, placebo-controlled study was carried out on adult patients with giardiasis. Group 1 (30 patients) included metronidazole 750 mg 3 times daily along with S. boulardii capsules (250 mg b.i.d. orally) for 10 d while group 2 (35 patients) was treated with metronidazole 750 mg 3 times daily and with empty capsules as placebo for 10 d. Patients were re-examined at 2 and 4 weeks after treatment, and stool examinations were performed. At week 2, G. lamblia cysts were detected in 6 cases (17.1%) of group 2 and none in group 1. At the end of the fourth week, presence of the cysts continued in the same 6 cases in group 2 (control group). These findings indicated that S. boulardii may be effective in treating giardiasis when combined with metronidazole therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Albendazole: a more effective antigiardial agent in vitro than metronidazole or tinidazole
Meloni, B. P., Thompson, R. C. A., Reynoldson, J. A., & Seville, P. (1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90324-8 · Cited by 81
Cited by
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients
McFarland, L. V. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i18.2202 · Cited by 545
Kelesidis, T., & Pothoulakis, C. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11428502 · Cited by 377
“…in patients with giardiasis resulted in a disappearance of Giardia cysts 2 weeks after start of the treatment in contrast to http://tag.sagepub.com 119 17.1% of patients treated with 10 days metronidazole as monotherapy who still had Giardia lamblia cysts in the stool [Besirbellioglu et al. 2006].”
ResultInfluentialAntimicrobial and Probiotic Properties of Yeasts: From Fundamental to Novel Applications
Hatoum, R., Labrie, S., & Fliss, I. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00421 · Cited by 338
Biotechnology of non-Saccharomyces yeasts—the ascomycetes
Johnson, E. A. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4497-y · Cited by 193
“Yeasts have also been hypothesized to prevent other intestinal infections, including inflammatory bowel disease and Crohn's disease (Besirbellioglu et al. 2006; Buts 2009; Dalmasso et al. 2006; Edwards-Ingram et al. 2007; Sougioultzis 2006; Villarruel et al. 2007).”
BackgroundGiardia spp. and the Gut Microbiota: Dangerous Liaisons
Fekete, E., Allain, T., Siddiq, A., Sosnowski, O., & Buret, A. G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.618106 · Cited by 86
Metadata
- Authors
- Besirbellioglu, B. A., Ulcay, A., Can, M., Erdem, H., Tanyuksel, M., Avci, I. Y., Araz, E., & Pahsa, A.
- Venue
- Scandinavian Journal of Infectious Diseases
- Publisher
- Informa UK Limited
- Published
- 2006-01
- Volume
- 38
- Issue
- 6-7
- Pages
- 479-481
- ISSN
- 0036-5548 (ISSN-L)
- 1651-1980
- OpenAlex
- W2087386008
- Cited by
- 60
- References
- 1
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Saccharomyces boulardii and infection due to Giardia lamblia. https://app.cochat.ai/papers/10.1080/00365540600561769
- The paper
- Besirbellioglu, B. A., Ulcay, A., Can, M., Erdem, H., Tanyuksel, M., Avci, I. Y., Araz, E., & Pahsa, A. (2006). Saccharomyces boulardii and infection due to Giardia lamblia. Scandinavian Journal of Infectious Diseases. https://doi.org/10.1080/00365540600561769
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.